ProteoNic's Partnership with Ginkgo Bioworks Elevates Access to Vector Technology
Wednesday, 13 March 2024, 11:17
ProteoNic partners with Ginkgo Bioworks
ProteoNic Biosciences has entered into a partnership with Ginkgo Bioworks, a move that promises to shape the future of biotechnology. The collaboration will provide clients with access to advanced vector technology, unlocking new possibilities in protein production and cell/gene therapy.
Enhanced Capabilities for Protein Production
- Efficiency: Customers can now streamline their production processes with cutting-edge vector technology.
- Precision: The collaboration ensures precise control over protein expression and engineering.
- Innovation: The partnership paves the way for revolutionary advancements in biopharmaceutical development.
By joining forces, ProteoNic and Ginkgo Bioworks aim to drive significant progress in the biotech sector, offering tailored solutions that cater to the evolving needs of the industry.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.